These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 15203749)

  • 21. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
    Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
    Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
    Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
    Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
    Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
    Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
    J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
    Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
    Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.
    Muirhead DM; Hoffman HT; Robinson RA
    J Clin Pathol; 2006 Jul; 59(7):711-5. PubMed ID: 16467168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
    Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
    Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
    Oshiro Y; Fukuda T; Tsuneyoshi M
    Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
    Miyagami M; Nakamura S
    No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical and electron microscopic study of subependymal giant cell astrocytoma.
    Huang MC; Kubo O; Tajika Y; Takakura K
    Noshuyo Byori; 1995; 12(2):117-23. PubMed ID: 8867692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of proliferative activity, apoptosis and expression of DNA topoisomerase II alpha in multimodally-treated oesophageal squamous cell carcinoma.
    Rees M; Stahl M; Klump B; Willers R; Gabbert HE; Sarbia M
    Anticancer Res; 2001; 21(5):3637-42. PubMed ID: 11848536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma].
    Yuge F; Hirakata H; Igarashi H; Kodama M; Kawata N; Takimoto Y
    Hinyokika Kiyo; 1999 Jul; 45(7):453-6. PubMed ID: 10466059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of MIB-1, PCNA indices, and p53 protein over-expression in intramedullary tumors of the spinal cord.
    Iwata K; Nakagawa H; Hashizume Y
    Noshuyo Byori; 1996 Apr; 13(1):73-8. PubMed ID: 8916130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of proliferative markers in central neurocytoma.
    Sharma MC; Rathore A; Karak AK; Sarkar C
    Pathology; 1998 Nov; 30(4):355-9. PubMed ID: 9839309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.